• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本神经白塞病的临床特征:一项多中心回顾性分析。

Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis.

机构信息

Department of Rheumatology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan.

出版信息

Mod Rheumatol. 2012 Jun;22(3):405-13. doi: 10.1007/s10165-011-0533-5. Epub 2011 Sep 21.

DOI:10.1007/s10165-011-0533-5
PMID:21935641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3375412/
Abstract

To delineate the clinical characteristics of neuro-Behçet's disease (NBD), a multicenter retrospective survey was performed in BD patients who had presented any neurological manifestations between 1988 and 2008. The diagnosis of acute NBD, chronic progressive (CP) NBD, and non-NBD was confirmed by retrospective review of clinical records. Data on a total of 144 patients were collected; 76 with acute NBD, 35 with CP NBD, and 33 with non-NBD. High-intensity lesions on T2-weighted magnetic resonance imaging (MRI) were found in 60.5% of the patients with acute NBD, 54.2% with CP NBD, and 42.4% with non-NBD, whereas brainstem atrophy was observed in 7.5% with acute NBD, 71.4% with CP NBD, and 9.0% with non-NBD. The cerebrospinal fluid (CSF) cell count was prominently elevated in patients with acute NBD, but was normal in about 15% of those with CP NBD. The sensitivity and specificity of the CSF cell count for the diagnosis of acute NBD versus non-NBD were 97.4 and 97.0%, respectively (cut-off 6.2/mm(3)). The sensitivity and specificity of CSF interleukin (IL)-6 for the diagnosis of CP NBD versus the recovery phase of acute NBD were 86.7 and 94.7%, respectively (cut-off 16.55 pg/ml). The results indicate that elevation of the CSF cell count and CSF IL-6 and the presence of brainstem atrophy on MRI are useful for the diagnosis of NBD.

摘要

为了描绘神经贝赫切特病(NBD)的临床特征,我们对 1988 年至 2008 年间出现任何神经系统表现的 BD 患者进行了一项多中心回顾性调查。急性 NBD、慢性进展性(CP)NBD 和非 NBD 的诊断通过回顾性临床记录进行确认。共收集了 144 例患者的数据;76 例为急性 NBD,35 例为 CP NBD,33 例为非 NBD。60.5%的急性 NBD、54.2%的 CP NBD 和 42.4%的非 NBD患者的 T2 加权磁共振成像(MRI)上有高强度病变,而急性 NBD 中有 7.5%、CP NBD 中有 71.4%、非 NBD 中有 9.0%的患者出现脑干萎缩。急性 NBD 患者的脑脊液(CSF)细胞计数明显升高,但 CP NBD 患者中约有 15%的细胞计数正常。CSF 细胞计数对急性 NBD 与非 NBD 的诊断的灵敏度和特异性分别为 97.4%和 97.0%(临界值为 6.2/mm(3))。CSF 白细胞介素(IL)-6 对 CP NBD 与急性 NBD 恢复期的诊断的灵敏度和特异性分别为 86.7%和 94.7%(临界值为 16.55pg/ml)。结果表明,CSF 细胞计数和 CSF IL-6 的升高以及 MRI 上脑干萎缩对 NBD 的诊断具有一定的辅助作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344b/3375412/0111da3b9947/10165_2011_533_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344b/3375412/6c269954b1ff/10165_2011_533_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344b/3375412/0111da3b9947/10165_2011_533_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344b/3375412/6c269954b1ff/10165_2011_533_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344b/3375412/0111da3b9947/10165_2011_533_Fig2_HTML.jpg

相似文献

1
Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis.日本神经白塞病的临床特征:一项多中心回顾性分析。
Mod Rheumatol. 2012 Jun;22(3):405-13. doi: 10.1007/s10165-011-0533-5. Epub 2011 Sep 21.
2
[Recent aspects of Neuro-Behcet's disease].[神经白塞病的近期研究进展]
Brain Nerve. 2013 Nov;65(11):1245-53.
3
Quantitative analysis of brainstem atrophy on magnetic resonance imaging in chronic progressive neuro-Behçet's disease.慢性进行性神经白塞病脑干萎缩的磁共振成像定量分析
J Neurol Sci. 2014 Feb 15;337(1-2):80-5. doi: 10.1016/j.jns.2013.11.020. Epub 2013 Nov 21.
4
Clinical features and disease course of neurological involvement in Behcet's disease: HUVAC experience.Behcet 病神经系统受累的临床特征和疾病进程:HUVAC 经验。
Mult Scler Relat Disord. 2020 Feb;38:101512. doi: 10.1016/j.msard.2019.101512. Epub 2019 Nov 9.
5
Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis.急性和慢性进展性实质型神经白塞病的临床特征差异:荟萃分析。
Sci Rep. 2017 Aug 31;7(1):10196. doi: 10.1038/s41598-017-09938-z.
6
[A case of chronic progressive neuro-Behçet disease with extensive cerebral atrophy and elevated CSF IL-6 activity treated with infliximab].
Rinsho Shinkeigaku. 2018 Jan 26;58(1):30-34. doi: 10.5692/clinicalneurol.cn-001086. Epub 2017 Dec 22.
7
[Analysis of the clinical characteristics of 25 cases with parenchymal neuro-Behcet's disease].[25例实质型神经白塞病临床特征分析]
Zhonghua Nei Ke Za Zhi. 2023 Jul 1;62(7):808-813. doi: 10.3760/cma.j.cn112138-20230126-00034.
8
Increased IL-22 in cerebrospinal fluid of neuro-behçet's disease patients.神经白塞病患者脑脊液中白细胞介素 22 增加。
Cytokine. 2024 Jul;179:156617. doi: 10.1016/j.cyto.2024.156617. Epub 2024 Apr 16.
9
Magnetic resonance imaging and proton magnetic resonance spectroscopy in neuro-Behçet's disease.神经白塞病的磁共振成像和质子磁共振波谱分析
Clin Exp Rheumatol. 2004 Sep-Oct;22(5):561-7.
10
Decreased Level of IL-37 Correlates Negatively with Inflammatory Cytokines in Cerebrospinal Fluid of Patients with Neuro-Behcet's Disease.神经白塞病患者脑脊液中白细胞介素-37水平降低与炎性细胞因子呈负相关。
Iran J Immunol. 2019 Dec;16(4):299-310. doi: 10.22034/IJI.2019.80281.

引用本文的文献

1
Case report: Adult case of A20 haploinsufficiency suspected as neuro-Behçet disease.病例报告:疑似神经白塞病的成人A20单倍体不足病例。
Front Immunol. 2025 Jan 7;15:1508307. doi: 10.3389/fimmu.2024.1508307. eCollection 2024.
2
Neuro-Behçet's disease: an update of clinical diagnosis, biomarkers, and immunopathogenesis.神经白塞病:临床诊断、生物标志物及免疫发病机制的最新进展
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae123.
3
Development of neuro-Behcet's disease in a patient with operable HER2-positive breast cancer during neoadjuvant chemotherapy: A case report.

本文引用的文献

1
Cyclosporine-related posterior reversible encephalopathy syndrome after heart transplantation: should we withdraw or reduce cyclosporine?: case reports.心脏移植术后环孢素相关的后部可逆性脑病综合征:我们应该停用还是减量环孢素?病例报告
Transplant Proc. 2009 Mar;41(2):716-20. doi: 10.1016/j.transproceed.2009.01.041.
2
CSF levels of cytokines in neuro-Behçet's disease.神经白塞病中脑脊液细胞因子水平
Clin Neurol Neurosurg. 2009 Jul;111(6):507-10. doi: 10.1016/j.clineuro.2009.02.001. Epub 2009 Mar 19.
3
Neuro-Behçet's disease: epidemiology, clinical characteristics, and management.
神经白塞病在接受新辅助化疗的可手术 HER2 阳性乳腺癌患者中的发生:一例报告。
Breast Dis. 2024;43(1):223-229. doi: 10.3233/BD-230026.
4
Association of high disease activity and serum IL-6 levels with the incidence of inflammatory major organ events in Behçet disease: a prospective registry study.白塞病患者疾病高活动度和血清 IL-6 水平与炎症主要器官事件发生的相关性:一项前瞻性登记研究。
Front Immunol. 2024 Apr 15;15:1354969. doi: 10.3389/fimmu.2024.1354969. eCollection 2024.
5
Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review.伴有神经精神并发症和表现的风湿性疾病中的脑脊液分析:一项叙述性综述
Diagnostics (Basel). 2024 Jan 23;14(3):242. doi: 10.3390/diagnostics14030242.
6
Neuro-Behçet With a Thalamic Lesion: A Case Report.伴有丘脑病变的神经白塞病:一例报告
Cureus. 2023 Sep 25;15(9):e45925. doi: 10.7759/cureus.45925. eCollection 2023 Sep.
7
Innate immune responses in Behçet disease and relapsing polychondritis.白塞病和复发性多软骨炎中的固有免疫反应。
Front Med (Lausanne). 2023 Jun 26;10:1055753. doi: 10.3389/fmed.2023.1055753. eCollection 2023.
8
Effect of Infliximab on Chronic Progressive Neuro-Behçet's Disease: Influence of the Timing of Introduction on the Patient Outcome.英夫利昔单抗治疗慢性进展性神经白塞病的效果:引入时机对患者结局的影响。
Intern Med. 2024 Feb 15;63(4):481-486. doi: 10.2169/internalmedicine.1969-23. Epub 2023 Jun 21.
9
Increased T-bet/GATA-3 and ROR-γt /Foxp3 Ratios in Cerebrospinal Fluid as Potential Criteria for Definite Neuro-Behçet's Disease.脑脊液中T-bet/GATA-3和ROR-γt/Foxp3比值升高作为确诊神经白塞病的潜在标准
J Clin Med. 2022 Jul 29;11(15):4415. doi: 10.3390/jcm11154415.
10
Surgical Treatment for Mesial Temporal Lobe Epilepsy Accompanied with Neuro-Behçet's Disease: A Case Report.伴神经白塞病的内侧颞叶癫痫的外科治疗:一例报告
NMC Case Rep J. 2021 Aug 7;8(1):405-411. doi: 10.2176/nmccrj.cr.2020-0218. eCollection 2021.
神经白塞病:流行病学、临床特征及管理
Lancet Neurol. 2009 Feb;8(2):192-204. doi: 10.1016/S1474-4422(09)70015-8.
4
Cyclosporine for Behçet's uveitis: is it associated with an increased risk of neurological involvement?环孢素治疗白塞氏葡萄膜炎:它与神经受累风险增加有关吗?
Clin Exp Rheumatol. 2008 Jul-Aug;26(4 Suppl 50):S84-90.
5
Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome.神经白塞病中的白细胞介素-6:与疾病亚型及长期预后的关联
Cytokine. 2008 Dec;44(3):373-6. doi: 10.1016/j.cyto.2008.10.007. Epub 2008 Nov 17.
6
HLA-B51 and cigarette smoking as risk factors for chronic progressive neurological manifestations in Behçet's disease.HLA - B51及吸烟作为白塞病慢性进行性神经表现的危险因素
Mod Rheumatol. 2007;17(1):81-2. doi: 10.1007/s10165-006-0541-z. Epub 2007 Feb 20.
7
Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.英夫利昔单抗成功治疗难治性神经白塞病:通过磁共振成像、经颅磁刺激和细胞因子谱显示其疗效的病例报告
Ann Rheum Dis. 2007 Jan;66(1):136-7. doi: 10.1136/ard.2006.056804.
8
Headache in Behçet's syndrome.白塞病中的头痛
Headache. 2005 Jul-Aug;45(7):911-9. doi: 10.1111/j.1526-4610.2005.05160.x.
9
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis.视神经脊髓型多发性硬化症中鞘内IL-17/IL-8轴的激活
Brain. 2005 May;128(Pt 5):988-1002. doi: 10.1093/brain/awh453. Epub 2005 Mar 2.
10
Behçet's syndrome and the nervous system.白塞病与神经系统
Curr Opin Neurol. 2004 Jun;17(3):347-57. doi: 10.1097/00019052-200406000-00017.